|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.07 USD | +1.58% |
|
-2.39% | -1.70% |
| 04-23 | National Health Investors CFO John Spaid to Retire | MT |
| 04-23 | National Health Investors, Inc. Announces Executive Changes | CI |
Company Valuation: National Health Investors, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,635 | 2,266 | 2,424 | 3,148 | 3,638 | 3,639 | - | - |
| Change | - | -14.01% | 7% | 29.83% | 15.58% | 0.02% | - | - |
| Enterprise Value (EV) 1 | 3,841 | 3,394 | 3,537 | 4,270 | 4,782 | 4,524 | 4,911 | 5,053 |
| Change | - | -11.63% | 4.22% | 20.7% | 12.01% | -5.41% | 8.56% | 2.88% |
| P/E ratio | 23.6x | 35.3x | 17.8x | 22.1x | 25.3x | 20.9x | 21.4x | 21.5x |
| PBR | 1.75x | 1.77x | 1.93x | 2.32x | 2.42x | 2.26x | 2.07x | - |
| PEG | - | -0.9x | 0x | - | -7.2x | 1.1x | -9.68x | -47.5x |
| Capitalization / Revenue | 8.82x | 8.14x | 7.58x | 9.39x | 9.69x | 8.45x | 8.12x | 7x |
| EV / Revenue | 12.9x | 12.2x | 11.1x | 12.7x | 12.7x | 10.5x | 11x | 9.72x |
| EV / EBITDA | 14.4x | 13.5x | 14.2x | 16.3x | 16.6x | 14.7x | 14.6x | 15.5x |
| EV / EBIT | 20.7x | 18.8x | 19.7x | 22.3x | 23.1x | 22.5x | 20.9x | 19.3x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 3.802 | 3.6 | 3.6 | 3.6 | 3.64 | 3.722 | 3.812 | 3.743 |
| Rate of return | 6.62% | 6.89% | 6.45% | 5.19% | 4.77% | 4.96% | 5.08% | 4.99% |
| EPS 2 | 2.44 | 1.48 | 3.13 | 3.13 | 3.02 | 3.585 | 3.506 | 3.49 |
| Distribution rate | 156% | 243% | 115% | 115% | 121% | 104% | 109% | 107% |
| Net sales 1 | 298.7 | 278.2 | 319.8 | 335.2 | 375.6 | 430.9 | 448.4 | 520 |
| EBITDA 1 | 266.6 | 251.8 | 249.6 | 262.6 | 287.6 | 308.3 | 336.8 | 326.6 |
| EBIT 1 | 185.8 | 180.9 | 179.6 | 191.1 | 206.7 | 200.8 | 235.3 | 262.4 |
| Net income 1 | 111.8 | 66.4 | 135.6 | 137.9 | 142 | 172.6 | 178 | 189.2 |
| Net Debt 1 | 1,205 | 1,128 | 1,113 | 1,122 | 1,144 | 885 | 1,272 | 1,414 |
| Reference price 2 | 57.47 | 52.22 | 55.85 | 69.30 | 76.37 | 75.07 | 75.07 | 75.07 |
| Nbr of stocks (in thousands) | 45,851 | 43,389 | 43,410 | 45,422 | 47,639 | 48,471 | - | - |
| Announcement Date | 22/02/22 | 21/02/23 | 20/02/24 | 25/02/25 | 26/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 20.94x | 10.5x | 14.68x | 4.96% | 3.64B | ||
| 73.48x | 11.89x | 31.3x | 1.44% | 150B | ||
| 139.72x | 7.87x | 21.75x | 2.4% | 42.08B | ||
| 21.62x | 17.29x | 15.03x | 5.81% | 13.74B | ||
| 78.82x | 8.34x | 14.62x | 6.21% | 13.55B | ||
| 64.06x | 3.36x | 20.47x | 2.07% | 9.52B | ||
| 26.66x | 16.97x | 18.01x | 3.76% | 8.82B | ||
| 12x | 23.58x | 27.46x | 5.7% | 7.11B | ||
| 102.76x | - | - | 2.87% | 5.13B | ||
| 30.32x | 8.64x | 15.56x | 5.83% | 5.19B | ||
| Average | 57.04x | 12.05x | 19.88x | 4.11% | 25.91B | |
| Weighted average by Cap. | 77.12x | 11.42x | 26.41x | 2.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- NHI Stock
- Valuation National Health Investors, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















